 |
sirukumab |
|---|---|
| Trade Name | Plivensia� |
| Orphan Indication | Juvenile idiopathic arthritis (JIA) in pediatric patients |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-03 00:00:00 |
| Sponsor | Janssen Research & Development, LLC;1400 McKean Road, P.O. Box 776;Spring House, Pennsylvania, 19477 |
